Results 161 to 170 of about 36,737 (275)

Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment [PDF]

, 2018
Morie A. Gertz
openalex   +1 more source

Cardiac light chain amyloidosis secondary to Waldenström's macroglobulinemia: A case report and review. [PDF]

Exp Ther Med
Du F, Guilan A, Zhou L, Liu D, Chen J, Xiang H, Lu W, Liu J, Luo Y, Chen H.   +9 more
europepmc   +1 more source

Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan

, 2007
Ping Zhou, Julie Teruya‐Feldstein, Ping Lu, Martin Fleisher, Adam B. Olshen, Raymond L. Comenzo   +5 more
openalex   +1 more source

P5844Predictors of progression of light-chain cardiac amyloidosis [PDF]

, 2017
А.С. Рамеева, Ksenia Vedanova, В. В. Рамеев, А. Ф. Сафарова, Irina Bobkova, L V Kozlovskaya, Sergey Moiseev   +6 more
openalex   +1 more source

Cryo-EM structure of renal AL amyloid fibrils from a patient with λ1 light chain amyloidosis. [PDF]

Nat Commun
Yu C, Ma Y, Li H, Liu K, Huang H, Zhao K.   +5 more
europepmc   +1 more source

Adequate Antibody Response to COVID-19 Vaccine in Patients with Monoclonal Gammopathies and Light Chain Amyloidosis

, 2021
Alan H.B. Wu, Chia-Ching Wang, Chui Mei Ong, Kara L. Lynch   +3 more
openalex   +2 more sources

Safety and efficacy of elranatamab in patients with relapsed and/or refractory immunoglobulin light-chain amyloidosis. [PDF]

Blood
Vianna P, Chakraborty R, Hossain S, Bhutani D, Miller S, Rossi A, Cuddy SAM, Falk RH, Lentzsch S, Laubach JP, Bianchi G.   +10 more
europepmc   +1 more source

Case for diagnosis. Systemic light chain amyloidosis with cutaneous involvement [PDF]

, 2017
João Renato Vianna Gontijo, Jackson Machado‐Pinto, Maysa Carla de Paula   +2 more
openalex   +1 more source

Diagnostic pathways, cardiac manifestations, and outcomes in light chain amyloidosis: a plain language summary. [PDF]

Future Cardiol
Lyons G, Thompson J, Lousada I, Catini J, Manwani R, Maurer MS.   +5 more
europepmc   +1 more source

Recent developments in systemic light-chain amyloidosis prognosis and treatment. [PDF]

Future Cardiol
Ioannou A.
europepmc   +1 more source